Experts: Provide more funding for TB drugs, vaccines

Health experts on Thursday called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people worldwide last year. With the exception of Pfizer's rifabutin, a drug used to treat TB for those with drug-resistant HIV/AIDS, there have been no newly licensed drugs for TB in 40 years. Report

Suggested Articles

Inovio CEO J. Joseph Kim is undeterred by short sellers and other detractors who doubt his company can shuttle a COVID-19 DNA vaccine to market.

Adding entinostat to hormone therapy did not help patients with HR-positive, HER2-negative breast cancer live longer.

The data add to the evidence in support of the IL-6 drug ahead of a FDA decision to approve it in a rare disease served by Alexion’s Soliris.